Global Saliva Glucose Biosensor Market by Distribution Channel (Online, Offline) by End-user (Hospitals, Home Care, Clinics): Growth, Future Prospects, and Competitive Analysis, 2015 - 2027

Non-invasive glucose meters are existing around for quite a long time now. Saliva Glucose Biosensor is one of the significant products marking its presence in rapidly growing non-invasive glucose meter industry. As the name suggest, Saliva Glucose Biosensor uses saliva for measuring sugar level in patients instead of blood. Saliva Glucose Biosensor is most innovative glucose meters employed for diabetes management. Saliva Glucose Biosensor offers an instant and real tine analysis of glucose levels in patients. Analysis glucose levels can be accessed via mobile app installed on smartphones. Global Saliva Glucose Biosensor market is expected to generate cumulative value of USD 1,013.67 million over the span between 2021 to 2027. Compound annual growth rate of the Saliva Glucose Biosensor market will be slight under 9.5% during the forecast period.     

Global Saliva Glucose Biosensor Market

Interesting Facts of Saliva Glucose Biosensor

  • Saliva Glucose Biosensor is one of the first non-invasive glucose measurement devices
  • Large chunk of global Saliva Glucose Biosensor revenue stems from North America
  • China, India, Japan and South Korea are all set to witness rapid growth in demand for Saliva Glucose Biosensor
  • COVID 19 has considerable impact on production as well as demand for Saliva Glucose Biosensor during the second quarter of 2020, however, demand bounced back to pre-COVID 19 level in few months
  • Rapidly increasing geriatric population with rising prevalence of diabetics around the world, the demand for Saliva Glucose Biosensor is likely to be high in the years to come

Rising Prevalence of Diabetes around the world

World is witnessing rapid growth in diabetic population than ever before. Worldwide diabetic population reached to all time high in 2019 with just under 10% of the entire population suffering from diabetes. Diabetic population counted to over 460 million in 2019 and expected to reach over 575 million in 2030. Urban population has been found to be more prone to diabetes as compared to rural population. Incidence rate of diabetes is higher in urban areas measuring up to 10 to 11%. While rural population is less prone to diabetes with incidence rate of below 7%. Changing lifestyle, growing obesity, changing food habits, etc. are some of the major reasons for diabetes. With increasing prevalence of diabetes, the demand for Saliva Glucose Biosensors is expected to go up.

Saliva Glucose Biosensors Market is Governed by U.S.

Increasing diabetic population coupled with presence of Saliva Glucose Biosensor manufacturers in the region is fuelling the demand in U.S. Higher healthcare awareness, deep routed distribution channels, higher purchasing power parity, and better response from the patients to innovative products is also contributing towards the growth of Saliva Glucose Biosensor in the country. However, Germany, UK and France are also adding up to growing demand for Saliva Glucose Biosensor. Asia Pacific holds huge growth potential being home for huge population and highest number of diabetic patients in the world. India and China are expected to offer excellent future growth opportunities for the Saliva Glucose Biosensor manufacturers.

Build Your Business Case with Help of Credence Research 

Global Saliva Glucose Biosensor Market report published by the Credence Research not only provides critical insights but also assist in building business case for the new entrants or investors. The report titled “Saliva Glucose Biosensor” market is carefully drafted keeping in mind all prospective readers such as manufacturers, investors and consultants. Credence Research’s team of expert analysts’ extent end-to-end support to the clients in order to assist them in making strategic decision and achieve their gaols.

Innovation is a Key to Success

Major players operating in the global Saliva Glucose Biosensor market are highly focused on research & development in order to develop and commercialize innovative products. iQ Group Global, Abbott, DexCom, Ascensia Diabetes Care, Senseonics, Parexel and GBS Inc. are some of the leading manufacturers of Saliva Glucose Biosensor. In January 2019, iQ Group Global came up with its innovative non-invasive glucose meter based on ground-breaking Saliva Glucose Biosensor technology. Key players are focusing on facilitating patients to precisely analyse their glucose levels and easily understand it.  

Frequently asked questions about global Saliva Glucose Biosensor industry

Major players in global Saliva Glucose Biosensor market include iQ Global, DexCom, Abbott, Senseonics, Parexel, etc. All major players are focused on R&D for the development of innovative products and their commercialization in order to have competitive gain over rivals. Most of the players are mainly focused on achieving organic growth through new product launches, regional expansion and strengthening their distribution network.

Saliva Glucose Biosensor industry still in nascent stage in emerging economies with huge potential to grow in future. With highest population of diabetic people yet lack of heath awareness and limited spending power the region lacks behind Europe and North America at present. However, growing forward it offers tremendous growth opportunities for the companies.

Huge demand for Saliva Glucose Biosensors in North America and Europe mainly driving the demand for Saliva Glucose Biosensors.

COVID 19 had negative impact global Saliva Glucose Biosensor industry. However, the industry has rapidly overcome the negative consequences of COVID 19

Global Saliva Glucose Biosensor market is expected to exhibit CAGR of around 9.5% during the forecast period

Choose License Type
Published Date:  Aug 2021
Category:  Pharmaceuticals
Report ID:   60403
Report Format:   PDF
Pages:   120
Rating:    4.4 (63)
Connect With Us
24/7 Research Support